Pharmaguideline training
SOP for Out of Specification (OOS) for Pharmaceutical Results
Standard operating procedure to handle the out of specification results during the analysis of Pharmaceutical products and its investigation report during different stages.
1.0 PURPOSE
The purpose of this SOP (Standard Operating Procedure) is to describe the procedure for handling out of specification results obtained during
analysis.
2.0 SCOPE
This SOP is applicable to the results, which is out of specification obtained in Quality Control Laboratory for Raw/ packaging materials, finished
products for releasing parameters. This SOP is not applicable for informative parameters.
3.0 RESPONSIBILITY
3.1 Quality Control Analyst:
3.1.1 To inform out of specification results to the quality control in-charge.
3.2 Quality control in-charge
3.2.1 To issue out of specification investigation form after entering in the form in out of specification logbook.
3.2.2 To investigate out of specification results.
4.0 ACCOUNTABILITY
4.1 Quality Head
4.1.1 To verify the investigation form at each and every stage and to give a final conclusion about the status of the material.
5.0 PROCEDURE
5.1 On the receipt of the report for the Out of Specification (OOS) of results from the analyst, Q.C. Incharge shall issue OOS form after duly entering
in the out of specification log book.
5.2 QC In charge or designee shall carry out the investigation and fill in the form (Stage A). Quality control consulting
5.3 If it is found that the parameter of stage A is not satisfactory, any error is reported, correct the parameter and the same sample shall be
reanalyzed by another analyst.
5.4 If the material meets the requirement (passes), release the material; the analyst shall be re-trained for the error parts.
5.5 If the parameter of stage A is found satisfactory, the Supervisor shall allot the same material for reanalysis to another senior analyst. (Stage B).
5.6 If (Stage B) result is within specification (passes), the material shall be reanalyzed by the first analyst with same sample material and to
investigate the first analysts.
5.7 If the investigation of first analysts found satisfactory then release the material.
5.8 If the material fails in Stage B also, by senior analyst, simultaneously analyze after re-sample with the previously approved material (Stage C).
5.9 Material under investigation (Stage C) should be re-sampled with the authorization of Head Quality and then proceeds for the further analysis
(Stage C)
5.10 If the material has been received the first time, no previous sample is available, then stage (C) is not applicable and rejects the material.
5.11 If the previously approved material passes within the specification and the material under investigation fails to meet the specification, the
material shall be rejected.
5.12 If the previously approved material passes within the specification and the material under investigation also with the specification than the
material shall be reanalyzed by another analyst and investigate the second analysis (Stage B).
Discover related topics
Root Cause Analysis in Pharma Industry Ppt
Bioburden Testing Sop
Investigation Tools in Pharma
Microbiology Lab Layout in Pharmaceutical Industry
Out of Specification Sop
5.13 If the investigation of second analysis (Stage B) found satisfactory than release the material.
5.14 The repeat analysis can be carried out in separate sheet allotted by the supervisor duly authorized or in the particular hard book and all printouts
shall be attached with the document.
5.15 Cross-references of analysis shall be attached to OOS investigation form.
5.16 Final conclusion shall be made in the OOS investigation form for rejection/ approval by Quality Head.
5.17 Cross-reference of OOS investigation form shall be given in the analytical report.
6.0 ABBREVIATIONS
6.1 SOP - Standard operating procedure
6.2 OOS - Out of Specification
ATTACHMENT – 1
GENERAL DETAILS
Form No: Issued by:
Issued to: Date:
Product / Item:
Batch No. / Lot No.:
Stage:
Out of Specification Test:
Analyzed by: __________ Date: __________ Reference: __________
Details of Investigation
STAGE A
S.No. ITEM Observation Sign
1. Condition of sample to be checked.
2. Balance checked for its calibration.
3. Instrument Calibration checked.
4. Volumetric standard / reagent used for analysis checked for its validity.
5. Analytical template/Hard book checked for dilution, calculation, weighing Titer values
and readings.
6. Working standard checked for its validity.
7. Chromatograms / printouts / TLC plates checked
8. Glassware checked for its accuracy and Calibration.
Remark of the investigator: Not Satisfactory/ Satisfactory
Sign: __________ Date: __________
Stage B
Repeat analysis allotted to:
Date:
Observation of the result:
Analyzed By: __________ Date: __________ Reference: __________
Remark of the investigator :
Sign: __________ Date: __________
Note: If the material fails in the above stage i.e. Stage B, the material will resample with the authorization shall be Analyzed by Senior analyst
along with the previously approved material.
MATERIAL /PRODUCT RESAMPLE AUTHORIZATION FORM
AR NO.: QTY.: Authorization Sampled
By/Date: By/Date:
Stage C
Name of the Senior chemist: Date of analysis:
Approved batch taken for comparison:
Observation of the result:
Approved batch ():
Current Batch ():
Analyzed By:__________ Date:__________ Reference:__________
FINAL CONCLUSION :
HEAD QUALITY: __________ Date: _________
Attachments : Stage A __________
Stage B __________
Stage C __________
Investigation report
ATTACHMENT – 2
OOS APPLICABLE OOS NOT APPLICABLE
Sr. No. TESTS of Releasing Parameters Sr. No. TESTS of Informative Parameters
1. Identification 1. Description
2. Assay 2. Particle Size Distribution (Sieve tests)
3. Related Substances / Chromatographic purity / Degradation 3. Bulk Density
profiles. 4. Physical parameters (i.e. Hardness, Friability,
4. Solubility dimensions)
5. Dissolution (USP guidelines to be followed)
Content Uniformity (USP guidelines to be followed.
6. Chemical purity tests (i.e. Melting points/ Colour index,
chlorides/ sulphates, SOR, etc)
7. Text matters, Grammage, Colour scheme.
8.
Ankur Choudhary is India's first professional pharmaceutical blogger, author and founder of pharmaguideline.com, a widely-read pharmaceutical
blog since 2008. Sign-up for the free email updates for your daily dose of pharmaceutical tips.
Need Help: Ask Question
Pharmaguideline training
© Pharmaguideline, 2008-2024. All Rights Reserved.
Setup ❘ Terms of Use ❘ FAQ
